메뉴 건너뛰기





Volumn 14, Issue 1, 2000, Pages 34-52

Leukocyte reduction of blood components: Public policy and new technology

(11)  Dzik, Sunny a,b,c,d,e,f,g,h,i,j   Aubuchon, James a,b,c,d,e,f,g,h,i,j   Jeffries, Leigh a,b,c,d,e,f,g,h,i,j   Kleinman, Steven a,b,c,d,e,f,g,h,i,j   Manno, Catherine a,b,c,d,e,f,g,h,i,j   Murphy, Michael F a,b,c,d,e,f,g,h,i,j   Popovsky, Mark A a,b,c,d,e,f,g,h,i,j   Sayers, Merlin a,b,c,d,e,f,g,h,i,j   Silberstein, Leslie E a,b,c,d,e,f,g,h,i,j   Slichter, Sherril J a,b,c,d,e,f,g,h,i,j   Vamvakas, Eleftherios C a,b,c,d,e,f,g,h,i,j  


Author keywords

[No Author keywords available]

Indexed keywords

ALLOIMMUNIZATION; BLOOD TRANSFUSION; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; CREUTZFELDT JAKOB DISEASE; CYTOMEGALOVIRUS INFECTION; FEVER; HUMAN; IMMUNOMODULATION; LEUKOPENIA; POLICY; REVIEW; VIRUS TRANSMISSION;

EID: 0033970908     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-7963(00)80114-5     Document Type: Article
Times cited : (107)

References (104)
  • Reference 정보가 존재하지 않습니다.

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.